OPHTHALMIC DRUG DELIVERY SYSTEM AND METHOD

• US 20110125090A1
• Filed: 01/06/2011
• Published: 05/26/2011
• Est. Priority Date: 11/13/2008
• Status: Abandoned Application

• Current Assignee: Gholam A. Peyman
• Original Assignee: Gholam A. Peyman
• Inventors: Peyman, Gholam A.
• Application Number:
  US12/985,758
• Publication Number:
  US 20110125090A1
• Time in Patent Office: Days
• US Class Current: 604/93.01
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61K 31/365 Lactones
• CPC Class Codes: A61K 31/436 the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
• CPC Class Codes: A61K 38/13 Cyclosporins
• CPC Class Codes: A61K 9/0051 Ocular inserts, ocular implants
• CPC Class Codes: A61P 27/02 Ophthalmic agents

Abstract

An ocular device comprising a biodegradable, and absorbable body configured in a shape for implanting

• • directly exterior and anterior to a crystalline lens capsule in a patient'"'"'s eye shaped in a C configuration or a ring configuration to stably lay on zonules or the anterior lens capsule or an intraocular lens (IOL) between an iris and an outer surface of the lens capsule, or
  • in the choroid shaped in straight rod configuration or in a snake-shaped semicircle configuration to follow the inside curvature of the sclera and readily position inside the suprachoroidal space, or
  • under the retina shaped in a rod configuration or a semicircle configuration
    the device comprising a deformable material such that the device is folded upon implantation, the device optionally containing an ocular therapeutic agent released upon implanting in the patient'"'"'s eye.

Claims

1. An ocular device comprising a biodegradable, and absorbable body configured in a shape for implanting

directly exterior and anterior to a crystalline lens capsule in a patient'"'"'s eye shaped in a C configuration or a ring configuration to stably lay on zonules or the anterior lens capsule or an intraocular lens (IOL) between an iris and an outer surface of the lens capsule, or

in the choroid shaped in straight rod configuration or in a snake-shaped semicircle configuration to follow the inside curvature of the sclera and readily position inside the suprachoroidal space, or

under the retina shaped in a rod configuration or a semicircle configuration

the device comprising a deformable material such that the device is folded upon implantation, the device optionally containing an ocular therapeutic agent released upon implanting in the patient'"'"'s eye.

2. The device of claim 1 sized between 8 mm diameter and 18 mm diameter, inclusive.

3. A method of treating a patient by administering the device of claim 1 and intravitreally injecting the ocular therapeutic agent.

4. The device of claim 1 containing a liquid medium in which an agent is suspended.

5. The device of claim 1 containing a therapeutic agent in the device.